Development of a first-in-class antibody and a specific assay for α-1,6-fucosylated prostate-specifi...
Development of a first-in-class antibody and a specific assay for α-1,6-fucosylated prostate-specific antigen
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Prostate-specific antigen (PSA) levels are widely used to screen for prostate cancer, yet the test has poor sensitivity, specificity and predictive value, which leads to overdiagnosis and overtreatment. Alterations in the glycosylation status of PSA, including fucosylation, may offer scope for an improved biomarker. We sought to generate a monoclon...
Alternative Titles
Full title
Development of a first-in-class antibody and a specific assay for α-1,6-fucosylated prostate-specific antigen
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ef98887a925b43faa0aac0379ac42831
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ef98887a925b43faa0aac0379ac42831
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-67545-1
